172 related articles for article (PubMed ID: 21725800)
21. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma.
Wilson M; Gill SK; MacPherson L; English M; Arvanitis TN; Peet AC
Clin Cancer Res; 2014 Sep; 20(17):4532-9. PubMed ID: 24947932
[TBL] [Abstract][Full Text] [Related]
23. [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
Zhang S; Wu Y; Feng D; Zhang Z; Jiang F; Yin R; Xu L
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):317-22. PubMed ID: 21496429
[TBL] [Abstract][Full Text] [Related]
24. Expression and regulation of AC133 and CD133 in glioblastoma.
Campos B; Zeng L; Daotrong PH; Eckstein V; Unterberg A; Mairbäurl H; Herold-Mende C
Glia; 2011 Dec; 59(12):1974-86. PubMed ID: 21901757
[TBL] [Abstract][Full Text] [Related]
25. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
27. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
28. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.
Yasuda H; Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Kawamoto A; Inoue Y; Miki C; Kusunoki M
Oncol Rep; 2009 Oct; 22(4):709-17. PubMed ID: 19724847
[TBL] [Abstract][Full Text] [Related]
29. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D
Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.
Coco C; Zannoni GF; Caredda E; Sioletic S; Boninsegna A; Migaldi M; Rizzo G; Bonetti LR; Genovese G; Stigliano E; Cittadini A; Sgambato A
J Exp Clin Cancer Res; 2012 Sep; 31(1):71. PubMed ID: 22964035
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling and natural killer cell infiltration in tumor tissues underlie medulloblastoma prognosis.
Liang KH; Chang CC; Wu KS; Yu AL; Sung SY; Lee YY; Liang ML; Chen HH; Fen JJ; Chao ME; Liao YT; Wong TT
Sci Rep; 2021 Dec; 11(1):23282. PubMed ID: 34857809
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.
Genovesi LA; Carter KW; Gottardo NG; Giles KM; Dallas PB
PLoS One; 2011; 6(9):e23935. PubMed ID: 21931624
[TBL] [Abstract][Full Text] [Related]
36. Identification of a cancer stem cell in human brain tumors.
Singh SK; Clarke ID; Terasaki M; Bonn VE; Hawkins C; Squire J; Dirks PB
Cancer Res; 2003 Sep; 63(18):5821-8. PubMed ID: 14522905
[TBL] [Abstract][Full Text] [Related]
37. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.
Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M
Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089
[TBL] [Abstract][Full Text] [Related]
38. Arsenite inhibits the function of CD133
Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
[TBL] [Abstract][Full Text] [Related]
39. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer.
Peng S; Maihle NJ; Huang Y
Oncogene; 2010 Apr; 29(14):2153-9. PubMed ID: 20101213
[TBL] [Abstract][Full Text] [Related]
40. CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres.
Walter D; Satheesha S; Albrecht P; Bornhauser BC; D'Alessandro V; Oesch SM; Rehrauer H; Leuschner I; Koscielniak E; Gengler C; Moch H; Bernasconi M; Niggli FK; Schäfer BW;
PLoS One; 2011; 6(5):e19506. PubMed ID: 21602936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
